# Ceri Davies

> Ceri Davies is a seed investor at Takeda backing Medical, Biotechnology and Pharmaceutical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Takeda](https://shizune.co/investors/profile/takeda-pharmaceutical)
- Total investments: 1
- Last investment: Oct 2020
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ceri-davies-633358ab/

Ceri Davies is a seed investor at Takeda focused on Medical and Biotechnology. Ceri Davies - Head of CNS Drug Discovery Unit @ Takeda

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| XFOREST Therapeutics | xFOREST Therapeutics develops a drug discovery platform that targets RNA structures. |  | Seed | Oct 06, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [ANRI](https://shizune.co/investors/profile/anri) — VC Fund, 1 deal together

## About Takeda

VC Fund · Osaka, Japan

Takeda researches, develops, manufactures, sells, markets, imports, and exports pharmaceutical drugs. They offer pharmaceuticals, therapeutics, oncology, and gastroenterology vaccines.

5 contacts available at Takeda.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Plump | President, Research & Development | https://shizune.co/investors/profile/andrew-plump |
| Bin Li | Director of Computational Biology, Takeda Data Science Institute | https://shizune.co/investors/profile/bin-li |
| Ceri Davies | Head of CNS Drug Discovery Unit | https://shizune.co/investors/profile/ceri-davies-bcd7 |
| Christopher Barr | Takeda Community Engagement | https://shizune.co/investors/profile/christopher-barr |
| Masaru Otsuka | Head of Digital Acceleration | https://shizune.co/investors/profile/masaru-otsuka |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ceri Davies invest in?

Ceri Davies invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ceri Davies last invest?

The most recent investment recorded for Ceri Davies closed in Oct 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co